NCT00860249 Outreach for Patients That Are Newly Eligible for Colorectal Cancer Screening Status TERMINATED Phase NA
NCT00859768 The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients Status COMPLETED Phase NA
NCT00856375 NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00856115 Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal Cancer Status COMPLETED Phase N/A
NCT00855348 PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening Status COMPLETED Phase N/A
NCT00842257 Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00841282 RCT of Air Insufflation Versus Water Infusion Colonoscopy by Supervised Trainees Status COMPLETED Phase NA
NCT00838578 Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00838318 Colon Cancer Screening in First-Degree Relatives of Hispanic Colorectal Cancer (CRC) Patients Status COMPLETED Phase N/A
NCT00836992 Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer Status COMPLETED Phase N/A
NCT00836303 Trial of a Multilevel Intervention to Increase Colorectal Cancer Screening Status COMPLETED Phase NA
NCT00833508 Effect of Preoperative Chemoradiotherapy on Exercise Capacity as Measured by Cardiopulmonary Exercise Testing Status COMPLETED Phase NA
NCT00831571 Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin Status COMPLETED Phase N/A
NCT00831181 Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer Status COMPLETED Phase PHASE2
NCT00825110 SS-GCC1- Screening Study of Genetic Changes in Colorectal Cancer Status UNKNOWN Phase N/A
NCT00823810 Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT Status TERMINATED Phase NA
NCT00820417 Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib Status COMPLETED Phase PHASE1